Daniel Kobe

Daniel Kobe practices at Hunterdon Endosurgery Center in Flemington, New Jersey.

Daniel Kobe's NPI, 1073976411, was assigned on April 2, 2016. Daniel Kobe holds New Jersey license 25MA11725300.

Daniel Kobe's primary practice is Hunterdon Endosurgery Center, at 1100 Wescott Drive - Suite 204, Flemington, NJ 08822. The practice phone is (908) 788-6448.

Daniel Kobe's primary practice is Hunterdon Endosurgery Center in Flemington, New Jersey. Daniel Kobe is also affiliated with Hunterdon Medical Center. The medical group on file is Hunterdon Health. Dmand AI also links Daniel Kobe to 2 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Daniel Kobe practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Daniel Kobe's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Daniel Kobe's licenses on file in 3 states: New Jersey, Michigan and Ohio.

CMS data shows 5,454 Medicare services from Daniel Kobe across 32 procedure codes in 2024, for 1,718 Medicare patients. Medicare paid $324,939 for them.

CMS counts 1,718 Medicare patients who saw Daniel Kobe in 2024. The largest group is 75 to 84, with 698 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Daniel Kobe's median patient age at 70, with 48% women.

In 2024, Daniel Kobe wrote 5,413 Medicare Part D claims for 1,036 patients. 85% of them were for generic drugs. CMS names the drug for 5,113 of them, across 66 drugs with 11 or more claims each, at $1,594,687 in total drug cost. In 2023, CMS named 61 claims across 4 drugs.

Daniel Kobe accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Daniel Kobe, published from 2014 to 2024. The most frequent topics are Aortic Valve, Emergency Service, Hospital and Femoral Artery. Daniel Kobe has published most often in J Invasive Cardiol. Daniel Kobe's most frequent co-authors are Hiram G. Bezerra, MD, Marco A. Costa, MD and Alan H. Markowitz, MD.

CMS Open Payments shows 187 general payments to Daniel Kobe from 27 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $495.